10
panel
FasterCures Board and Advisors (Invite only)
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
video
Virtual Program | A Conversation with Marcella Nunez-Smith on COVID-19 and Health Equity
October 19 at 10:00 am PDT / 1:00 pm EDT
Guest
Marcella Nunez-Smith
video
The Global Future of Work in the Life Sciences
The life sciences are a crucially important source of innovation and jobs for communities around t
he world.
+ Read More
video
Virtual Program | COVID-19 Update: Variants, Vaccinations, Global Distribution
October 19 at 12:45 pm PDT /3:45 pm EDT
Despite global pandemic fatigue, SARS-CoV2 is still in ci
rculation around the world as we head into the winter of 2021. How close are we to achieving "community immunity" across continents?
+ Read More
video
The Impact of Investing in Health Equity in Biomedical Research
October 20 at 8:30 am PDT / 11:30 am EDT
Biomedical research relies on commercial investmen
t, grant funding, and private donations to accelerate drug development, run clinical trials, and support innovation in health technologies.
+ Read More
article
Comment Letter: Prescription Drug User Fee Act VII (PDUFA)
Submitted electronically
The Honorable Janet Woodcock, M.D.
Acting Commissioner
Food and Drug Admin
istration
Dockets Management Staff (HFA-305)
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
+ Read More